Every piece of efficacy and safety data we have comes from this dosing frequency
In SURPASS-2, which compared tirzepatide to semaglutide (a GLP-1 receptor agonist) in patients taking metformin, tirzepatide 5 mg, 10 mg, and 15 mg doses achieved mean HbA1c reductions of 2.01%, 2.24%, and 2.30% respectively from baseline, compared to 1.86% with semaglutide 1 mg
For higher doses (1.0 mg and above), the 10mg vial is more cost-effective because you use more of the vial contents within the 28-day window
Cadmium exposure in US adults, research based on the National Health and Nutrition Examination Survey from 1988 to 2018
Remember: No supplement is a replacement for a sound diet and lifestyle measures to respond to CFS
Tirzepatide also provides cardiorenal protective effects